In the third case, moderator Lisa J. Faia, MD presents her case of persistently active central retinal vein occlusion (CRVO), ...

The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...

Diabetic retinopathy (DR) is the primary cause of visual impairment among working-age populations in industrialized nations.

It has been approved for use in adult patients for the treatment of neovascular (wet) age related macular degeneration (AMD), visual impairment due to macular edema secondary to retinal vein occlusion ...

Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "Retinal Vein Occlusion Treatment Market by Treatment Type (Anti-VEGF Injection, Corticosteroid Treatment, Laser Therapy), Age Group (40-60 ...

Cencora is acquiring Retina Consultants of America for $4.6 billion, with potential additional contingent consideration of $500 million. The acquisition is subject to customary closing conditions and ...

“The combination of our financial resources, with Kalaris’ TH103 asset from the lab of the renowned Dr Napoleone Ferrara, will help accelerate the clinical development of TH103 for neovascular ...

Early hyperbaric oxygen therapy within 9 hours of symptom onset of central retinal artery occlusion may improve visual outcomes. CRAO generally causes severe acute vision loss but consensus guidelines ...

Webster targets the healthcare sector The private equity firm was founded in 2003 Cencora has agreed to acquire Retina Consultants of America, a management services organization of retina ...